The largest database of trusted experimental protocols

6 protocols using cd40 percp cy5

1

SPION^Dex Inhibition of DC Maturation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To investigate if SPIONDex inhibit DC maturation, iDCs were incubated in the presence of SPIONDex. Therefore, SPIONDex at iron concentrations of 50, 100 and 200 µg/mL were incubated with iDCs at a cell density of 106/100 µL in 6 well plates at 37 °C for 48 h. The DC medium containing IL-1β (200 U/mL), IL-6 (1000 µ/mL), tumor necrosis factor (TNF)-α (10 ng/mL, all from ImmunoTools, Friesoythe, Germany) and prostaglandin E2 (PGE2) (1 µg/mL, Pfizer, New York, USA) served as positive control, pure DC medium served as negative control. After 48 h of incubation, the matured DCs (mDCs) were harvested from the 6 well plates by washing with ice-cold PBS-EDTA. The cells were centrifuged at 200 rcf for 12 min, the supernatant removed and the cell number adjusted to 1 × 106/mL with PBS containing 2 vol% fetal calf serum (FCS). To analyze the expression of surface maturation markers, 50 µL cells were stained with fluorescence labelled antibodies (CD83-PE/Cy7, CD40-PerCP/Cy5.5, CD80-APC, CD86-PerCP/Cy5.5 (all from BioLegend, San Diego, CA, USA) in PBS containing 2% FCS for 30 min. Isotype antibodies were used as controls. Subsequently, cells were washed and fixated with 100 µL PBS containing 1% paraformaldehyde. Then, cells were analyzed in flow cytometry.
+ Open protocol
+ Expand
2

NLRP3 Regulates VSMC Apoptosis and Inflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
After culturing in serum‐free medium for 24 hours, primary VSMCs from NLRP3fl/fl or NLRP3SMC KO mice were treated with 20% CKD serum for 48 hours. Then VSMCs were collected for Annexin V/PI staining (BD Biosciences, San Jose, CA) to quantify VSMC apoptosis or injected intraperitoneally (105 cells per C57BL/6 mice). Twelve hours later, the peritoneal lavage fluid was collected for flow cytometry. The following fluorochrome‐conjugated antibodies were used: F4/80‐fluorescein isothiocyanate (eBioscience 11‐4801‐82, 1:50 dilution), MHC II‐PE (BD Biosciences 553566, 1:50 dilution), CD40‐PerCP Cy5.5 (Biolegend 124623, 1:50 dilution), and CD80‐PE Cy7 (Biolegend 104733, 1:50 dilution).
+ Open protocol
+ Expand
3

Evaluating DAC's Impact on DC Phenotype and Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
To detect the effect of DAC on the DC surface markers, DAC-treated and -untreated DCs were stained by anti-human CD86-APC, CD80-PE, HLA-DR-PE/Cy5, CD83-PE and CD40-PerCP-Cy5.5 (all antibodies were from BioLegend, San Diego, USA) at 4°C for 30 minutes. The expression of cell surface markers was detected by flow cytometry (FACSAira, BD Biosciences, Franklin Lakes, USA) and analyzed as the median fluorescence intensity (MFI). The histograms with overlays were made by FlowJo software (Treestar, Inc., San Carlos, USA).
To investigate whether DAC affects the function of DCs in relation to its effect on differentiating T cells into Th1/Th17 subsets, CD4+ cells were co-cultured with DAC-treated or -untreated DCs for 5 days as previously described [11 (link)]. Then 100 ng/ml PMA (Sigma-Aldrich, St. Louis, USA) and 1 μg/ml ionomycin (Sigma-Aldrich, St. Louis, USA) were added to the cells at 37°C for 1 hour and subsequently incubated for an additional 4 hours with 10 μg/ml brefeldin A (Sigma-Aldrich, St. Louis, USA). Anti- IFN-γ-FITC and IL-17A-PE antibodies (both from eBioscience, San Diego, USA) were used to perform the intracellular staining for 30 minutes at 4°C. The frequencies of CD4+ IFN-γ+ and CD4+ IL-17A+ cells were detected with the FACSAira flow cytometer (BD Biosciences, Franklin Lakes, USA).
+ Open protocol
+ Expand
4

Multi-color Flow Cytometry of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following mAbs and reagents were used: IgG1-FITC, IgG1-PerCP-Cy5.5, IgG2a-APC, IgG1-PB, CD14-PE, CD14-PErCP, CD45-HorizonV500, streptavidin-PerCP, anti-IFNγ-FITC, 7AAD and Lineage cocktail-FITC (CD3, 16,19, 20,14, 56) from BD Biosciences, Erembodegem, Belgium; CD80-FITC from Beckman Coulter, Woerden, the Netherlands; anti-BDCA1-PE, anti-BDCA2-FITC, anti-BDCA2-biotin, anti-BDCA4-PE, anti-BDCA3-APC, anti-Clec9a-VioBlue, CD19 microbeads and anti-PE-microbeads from Miltenyi Biotec, Bergisch Gladbach, Germany; CD1a-PB, CD209 (DC-SIGN)-PECy7, CD206-eFluor450, CD40-APC and CD274 (PDL1)-PECy7 from eBioscience, Vienna, Austria; CD86-APC, CD86-PB, CD163-PerCP-Cy5.5, CD40-PerCP-Cy5.5, HLA DR-APC-Cy7 and CD209 (DC-SIGN)-APC from Biolegend, London, United Kingdom. PMA, ionomycin and brefeldin A are from Sigma-Aldrich, St Louis, MO. The fix&perm cell permeabilization kit was obtained from An der Grub, Vienna, Austria.
+ Open protocol
+ Expand
5

Quantifying Myeloid Cell Phenotypes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies utilized for this study were purchased from Biolegend: CD45-FITC, CD11b-APC, MHCII-BV510, CD40-PerCP/Cy5.5, and CD83-BV650. These antibodies were used to ascertain the percent positive expression of MHC-II, CD40, and CD83 of myeloid cells in vitro. The protein expression of the cells was measured by suspending the macrophages in phosphate-buffered saline (PBS) and stained using fluorescent tags attached to antibodies that bind to unique components of the macrophages. The samples were passed through a flow cytometer, which contains lasers and photodetectors that analyzed protein expression within and outside of the cell by detecting the aforementioned bound fluorescence antibodies.
+ Open protocol
+ Expand
6

Splenic B Cell Subset Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleens were mechanically disrupted and red blood cells were osmotically lysed to generate a single cell suspension [13 (link)]. B220+ B cells were purified from splenocytes with a negative selection microbead kit obtained from Miltenyi Biotec. 0.5 × 106 splenic B cells were transferred to a 96 well plate and stained for 20 minutes on ice with a combination of B220-FITC (Miltenyi Biotec), IgM-PE (Southern Biotech), IgD-APC (Biolegend), CD19-PerCP/Cy5.5 (Biolegend), CD40-PerCP/Cy5.5 (Biolegend), CD21-APC/Cy7 (Biolegend), and MHC class II-PE (Bio X Cell) in 1× PBS supplemented with 0.1% BSA. The splenic B cell subsets analyzed were IgM+IgDloCD21lo, IgM+IgDhiCD21lo, IgM+IgDhiCD21hi, and IgM+IgDloCD21hi [12 (link), 19 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!